HMGB1 and Alzheimer disease: Given that HMGB1-RAGE axis triggers pro-inflammatory microglia activation through RAGE-NF-κB signaling pathway, targeting the HMGB1/RAGE/NF-κB signaling pathway may be a potential strategy for the treatment of AD (135).